Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patiromer in Hemodialysis Patients
NCT02033317Phase 2Terminated
- Sponsor
- Relypsa, Inc.
- Start
- Aug 2008
- Primary completion
- Dec 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of patiromer in hyperkalemia, sponsored by Relypsa, Inc.. Started Aug 2008; status: terminated.
02
Drugs
patiromer
03
Conditions
hyperkalemia
Beyond the preview
Go deeper on NCT02033317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033317.